Regen BioPharma, Inc.
RGBP · OTC
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1 | $121 | $51 | $727 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $95 | $0 | $254 | $219 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $64 | $10 | $31 | $48 |
| Total Curr. Assets | $160 | $131 | $336 | $994 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $18 | $223 | $223 | $218 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | -$223 | -$218 |
| Total NC Assets | $18 | $223 | $223 | $218 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $178 | $354 | $559 | $1,212 |
| Liabilities | – | – | – | – |
| Payables | $30 | $30 | $29 | $91 |
| Short-Term Debt | $815 | $607 | $1,274 | $3,583 |
| Tax Payable | $0 | $4 | $4 | $4 |
| Deferred Revenue | $1,465 | $1,607 | $1,718 | $1,844 |
| Other Curr. Liab. | $3,062 | $3,061 | $5,570 | $9,175 |
| Total Curr. Liab. | $5,372 | $5,308 | $8,595 | $14,698 |
| LT Debt | $0 | $150 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $150 | $3,021 | $0 |
| Other Liabilities | $0 | $0 | -$3,021 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $5,372 | $5,458 | $8,595 | $14,698 |
| Equity | – | – | – | – |
| Pref Stock | $1 | $0 | $48 | $48 |
| Common Stock | $1 | $0 | $503 | $435 |
| Retained Earnings | -$20,616 | -$19,749 | -$20,905 | -$23,349 |
| AOCI | $736 | $736 | $0 | $0 |
| Other Equity | $14,684 | $13,908 | $12,318 | $9,380 |
| Total Equity | -$5,194 | -$5,104 | -$8,036 | -$13,486 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $178 | $354 | $559 | $1,212 |
| Net Debt | $814 | $635 | $1,223 | $2,856 |